Antiviral Drugs Market 2028 By Mechanism of Action, Application, Type, Distribution Channel and Geography | The Insight Partners

Antiviral Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Mechanism of Action (Protease Inhibitors, Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitors, Others); Application (Hepatitis, HIV, Influenza, Herpes, Coronavirus Infection, Others); Type (Branded, Generic); Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00004068 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET OVERVIEW



Antiviral drugs are a type of medicine that is used to treat viral infections like HIV, herpes, hepatitis, and influenza. These antiviral drugs are generally administered in the form of vaccine but can also be given in the form of tablets, capsules, powders. Additionally, most of these drugs are utilized for specific viral infections, while a few (broad-spectrum antiviral drugs) are effective against a wide range spectrum of viruses. The global market for antiviral drugs is being driven by a rise in the rate of viral infections. In addition, the market is expected to grow due to an increase in R&D activities and the development of newer and advanced formulations, such as vaccines and combination therapy.

MARKET SCOPE



The "Global Antiviral Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antiviral drugs market with detailed market segmentation by mechanism of action, application, type and distribution channel. The report provides key statistics on the market status of the leading antiviral drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  •   Based on mechanism of action the market is segmented as, protease inhibitors, nucleotide polymerase inhibitor, reverse transcriptase inhibitors and others.
  •   Based on application the market is segmented as, hepatitis, HIV, influenza, herpes, corona virus infection and others.
  •   Based on type the market is segmented as, branded and generic.
  •   Based on distribution channel the market is segmented as, hospitals, retail pharmacies and online pharmacies.

MARKET DYNAMICS


Drivers:



  •   Increasing prevalences of viral infections across the globe is the key driver for the market growth.
  •   Extensive R&D efforts to develop and formulate advanced antiviral therapies, combination antivirus therapies.
  •   Increase in awareness about treatment of viral infetions is also expected to spur the market growth.

Restraints:



  •   However, risk of side effects after prolonged drug therapy is expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antiviral drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antiviral drugs market in these regions.

IMPACT OF COVID-19 ON ANTIVIRAL DRUGS MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the antiviral drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from antiviral drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for antiviral drugs in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antiviral drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •   F. Hoffmann-La Roche Ltd
  •   GlaxoSmithKline plc
  •   Merck Sharp and Dohme Corp
  •   Gilead Sciences, Inc
  •   Bristol-Myers Squibb Company
  •   Johnson and Johnson Services, Inc.
  •   Mylan N.V (Viatris)
  •   Dr. Reddy's Laboratories Ltd
  •   Cipla Inc
  •   Aurobindo Pharma USA
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • The List of Companies

    - F. Hoffmann-La Roche Ltd
    - GlaxoSmithKline plc
    - Merck Sharp and Dohme Corp
    - Gilead Sciences, Inc
    - Bristol-Myers Squibb Company
    - Johnson and Johnson Services, Inc.
    - Mylan N.V (Viatris)
    - Dr. Reddy's Laboratories Ltd
    - Cipla Inc
    - Aurobindo Pharma USA
    - Glenmark
    - Genentech
    - Abbott
    - Himalaya Wellness Company
    TIPRE00004068
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount